Pediatric bronchopneumonia, acute bronchitis
Conditions
Interventions
Control group:The control group children will receive routine diagnosis, treatment, and nursing care, excluding pediatric medical play services.
Experimental group:While receiving routine medical treatment and nursing services, the children in the experimental group will also receive children's medical play services.
Sponsors
Sichuan Province Chengdu City Shuangliu District Maternal and Child Health Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. the pediatric inpatient department of the hospital handles the hospitalized children who need treatment; 2. the child is conscious and can communicate normally; 3. the child's guardian has fully understood the research content and signed the written informed consent; 4. it meets the diagnostic criteria for bronchopneumonia or acute bronchitis in the code for the diagnosis and treatment of community acquired pneumonia in children (2019 version), and it is indeed necessary to be hospitalized after clinical evaluation.
Exclusion criteria
Exclusion criteria: 1. Severe underlying diseases: Exclude children with underlying conditions such as severe cardiorespiratory dysfunction, renal insufficiency, etc. 2. Acute abdomen (e.g., high fever convulsions, intussusception, intestinal obstruction, acute gastroenteritis, acute mesenteric lymphadenitis, etc.). 3. Mental or psychological disorders: Exclude children with severe mental or psychological disorders, such as schizophrenia, severe depression, etc. 4. Immunodeficiency or infectious diseases: Exclude children with immunodeficiency or infectious diseases to avoid cross-infection or other complications during medical guidance and ensure the safety of the children. 5. Parents or children refuse to participate in the study. 6. Observers who have been included and grouped but failed to complete treatment as required for various reasons (e.g., family withdrawal). 7. Observers who experience serious adverse events or reactions, develop other serious concurrent diseases, or have deteriorating conditions during clinical research, making it unsuitable for them to continue with the trial. 8. Observers with incomplete data that cannot be used to judge efficacy; observers who do not cooperate or withdraw on their own.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCARED,Score of children's anxiety mood disorder screening form;CMFS,Children's medical fear scale;Pediatric Treatment Compliance Observation Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| SDSC,Children's sleep disorder scale;Parents' satisfaction during hospitalization;Wong-Bake; | — |
Countries
China
Contacts
Public ContactXiaoqin Zhou
Sichuan Province Chengdu City Shuangliu District Maternal and Child Health Hospital
Outcome results
None listed